Pay in 4 interest-free payments of $6.75 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Shotsy does not provide medical advice, diagnosis, or treatment, so consult your healthcare provider before making medical decisions about your GLP1 medication
Most side effects diminish with continued use
At Cymbiotika, we believe that transparency is the foundation of a great wellness routine
1 Neuropathic pain is present in a significant subset of patients
This novel therapeutic candidate (HS-20094) studied in over 1,000 patients and administered as a weekly subcutaneous injection has demonstrated promising efficacy and safety clinical data, suggesting a potentially similar profile to the only Food and Drug Administration (FDA)-approved GLP-1/GIP receptor agonist, Eli Lilly's (NYSE: LLY) Zepbound (tirzepatide)
US$ 23.79
US$ 26.73
US$ 21.21
US$ 21.69
